Siddharth S. Matikonda, Ph.D.

Three-minute Thesis:

1. S. S. Matikonda, A. B. Gamble “Bioorthogonal prodrug activation strategy,” presented at New Zealand-Controlled Release Society (NZCRS) chapter’s meeting – 2014, Auckland, NZ.

2. S. S. Matikonda, A. B. Gamble “Aryl-allyl ether-based prodrugs for controlled and targeted delivery,” presented at D4 conference – 2014, Otago, NZ.

3.  S. S. Matikonda, A. B. Gamble “Bioorthogonal tools for prodrug activation,” presented at Frontiers in Chemistry – 2016, Otago, NZ.

 

Oral presentations:

1. S. S. Matikonda, M.J. Schnermann, "Mechanistic Basis and Implications of Cyanine Phototruncation," ACS San Diego, 2022, San Diego, USA.

2. S. S. Matikonda, "Basis and Implications of Cyanine Photoblueing, Cyanine Day-2022," Virtual.

3. S. S. Matikonda, M. J. Schnermann, “Core Remodelling leads to red-shifted Chromene Derivatives,” Janelia Research Farms (HHMI), Loudoun, USA.

4. S. S. Matikonda, M. Gomez, J. Ivanic, M. J. Schnermann, “LUMO Stabilization Leads to a New Generation of Red-Shifted Dyes,” Centre for Cancer Research, Fellows and Young Investigators – 2020, Frederick, USA.

5. S. S. Matikonda, J. M. Fairhall, A. B. Gamble, “Allyloxy ether-based, stable and tunable release-enabled self-immolative linkers for tumor-targeted prodrug therapy,” D4 conference – 2015, Otago, NZ.

6. S. S. Matikonda, A. B. Gamble, “Strain-promoted bioorthogonal prodrug activation strategy,” Postgraduate Symposia, Department of Chemistry – 2016, Otago, NZ.

 

Selected Poster presentations:

1. S. S. Matikonda, M. J. Schnermann, "Cyanine Phototruncation: From Mechanistic Analysis to Applications in Super Resolution Microscopy and Cell Tracking," International Society for Heterocyclic Chemistry, 2022, Santa Barbara, USA.

2. S. S. Matikonda, G. Hammersley, M. J. Schnermann, “LUMO stabilization provides far-red and NIR chromene and xanthene dyes” 12th Annual Frontiers in Chemical Biology – 2019, National Cancer Institute, USA.

3. S. S. Matikonda, J. M. Fairhall, F. Fiedler, S. Sanhajariya, R. Tucker, A. Garden, S. Hook, A. B. Gamble “Mechanistic evaluation of fluorine substitution on PABC linkers undergoing strain-promoted bioorthogonal prodrug activation” a poster presented at Gordon Research Conference and Gordon Research Seminar – 2017, New Hampshire, USA.

4. S. S. Matikonda, F. Fiedler, A. B. Gamble “Substituted PABC linkers to improve the bioorthogonal activation rate and stability of prodrugs” a poster presented at Pacific Chem – 2015, Honolulu, USA.

5. S. S. Matikonda, F. Fiedler, S. Sanhajariya, S. Hook, A. B. Gamble “Strategies to improve the bioorthogonal activation rate and stability of azido-PABC linked prodrugs” a poster presented at RACI Congress – 2016, Sydney, AUS.

6. S. S. Matikonda, J. M. Fairhall, A. B. Gamble “New “stable” and “tunable release” enabled self-immolative linkers for tumor-targeted prodrug therapy,” a poster presented at Cancer spotlight series – 2015, Wellington, NZ.

​